As of 2024-12-11, the Relative Valuation of Amphastar Pharmaceuticals Inc (AMPH) is 21.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 43.64 USD, the upside of Amphastar Pharmaceuticals Inc based on Relative Valuation is -50.5%.
The range of the Relative Valuation is 19.76 - 30.64 USD.
| Range | Selected | |
| Trailing P/E multiples | 6.1x - 9.3x | 6.5x |
| Forward P/E multiples | 6.6x - 9.8x | 7.0x |
| Fair Price | 19.76 - 30.64 | 21.59 |
| Upside | -54.7% - -29.8% | -50.5% |
| Date | P/E |
| 2024-12-10 | 13.38 |
| 2024-12-09 | 13.44 |
| 2024-12-06 | 13.43 |
| 2024-12-05 | 13.37 |
| 2024-12-04 | 13.59 |
| 2024-12-03 | 13.78 |
| 2024-12-02 | 14.07 |
| 2024-11-29 | 13.86 |
| 2024-11-27 | 13.86 |
| 2024-11-26 | 13.56 |
| 2024-11-25 | 13.69 |
| 2024-11-22 | 13.94 |
| 2024-11-21 | 13.66 |
| 2024-11-20 | 13.52 |
| 2024-11-19 | 13.38 |
| 2024-11-18 | 13.54 |
| 2024-11-15 | 13.68 |
| 2024-11-14 | 13.82 |
| 2024-11-13 | 13.95 |
| 2024-11-12 | 14.63 |
| 2024-11-11 | 14.90 |
| 2024-11-08 | 14.82 |
| 2024-11-07 | 14.13 |
| 2024-11-06 | 16.38 |
| 2024-11-05 | 15.81 |
| 2024-11-04 | 15.51 |
| 2024-11-01 | 15.56 |
| 2024-10-31 | 15.50 |
| 2024-10-30 | 15.57 |
| 2024-10-29 | 15.69 |
| 2024-10-28 | 15.77 |
| 2024-10-25 | 15.42 |
| 2024-10-24 | 15.22 |
| 2024-10-23 | 15.28 |
| 2024-10-22 | 15.45 |
| 2024-10-21 | 15.59 |
| 2024-10-18 | 15.59 |
| 2024-10-17 | 15.25 |
| 2024-10-16 | 15.59 |
| 2024-10-15 | 15.12 |
| 2024-10-14 | 15.12 |
| 2024-10-11 | 14.59 |
| 2024-10-10 | 14.20 |
| 2024-10-09 | 14.21 |
| 2024-10-08 | 14.19 |
| 2024-10-07 | 14.36 |
| 2024-10-04 | 14.33 |
| 2024-10-03 | 14.21 |
| 2024-10-02 | 14.26 |
| 2024-10-01 | 14.83 |